Featured news

Nanologica Publishes Information Document regarding Directed Share Issues and Rights Issue

Nanologica AB (publ) (”Nanologica” or ”the Company”) publishes an information document regarding the directed share issues of approximately SEK 13.7 million in total and rights issue of approximately SEK 82.5 million, before issue costs, which was resolved by the board of directors on 30 January 2026 and subsequently approved by the extraordinary general meeting held on 4 March 2026 (“The Issues”). The information document has been registered with the Swedish Financial Supervisory Authority and is

Read more »

Bulletin from the Extraordinary General Meeting in Nanologica AB (publ)

Nanologica AB (publ) (“Nanologica” or the “Company”) held an extraordinary general meeting today at which the following resolutions were passed. For more detailed information on the content of the resolutions, please refer to the complete notice of the extraordinary general meeting, which is available on the Company’s website, www.nanologica.com. Adoption of new articles of association The general meeting resolved to amend the articles of association, whereby the limits of the articles of association for share

Read more »

Year-End Report 2025 Nanologica AB (publ)

FINANCIAL SUMMARY Net sales for the fourth quarter amounted to SEK 5,205 thousand (6,715) and for the full year to SEK 21,127 thousand (14,538) Operating loss for the quarter amounted to SEK -15,706 thousand (-11,890) and for the full year to SEK -46,801 thousand (-59,255) Loss after tax for the quarter amounted to SEK -16,733 thousand (-14,033) and for the full year to SEK -51,289 thousand (-65,629) Earnings per share before and after dilution were

Read more »

JEREMIE TROCHU PROPOSED AS NEW BOARD MEMBER OF NANOLOGICA AB (PUBL)

Jeremie Trochu, CEO of the Ardena Group, is proposed as a new member of the board of directors of Nanologica AB. The proposal has been presented by Nanologica’s main owner Flerie Invest AB in connection with Nanologica’s acquisition of Ardena Södertälje AB. The proposal will be resolved at the Extraordinary General Meeting on March 4.   The proposal to elect Jeremie Trochu to Nanologica’s board of directors marks the continued collaboration between Nanologica and Ardena

Read more »

NOTICE OF EXTRAORDINARY GENERAL MEETING IN NANOLOGICA AB (PUBL)

The shareholders of Nanologica AB (publ), org.nr 556664-5023 (the “Company“) are hereby invited to attend the Extraordinary General Meeting to be held on Wednesday, March 4, 2026, at 10.00 a.m. CET at Advokatfirman Lindahl’s premises, at Smålandsgatan 16, Stockholm. Read more: Notice of Extraordinary General Meeting

Read more »

NANOLOGICA CARRIES OUT DIRECTED SHARE ISSUES OF APPROX. SEK 13.7 MILLION IN TOTAL, AND A FULLY SECURED RIGHTS ISSUE OF APPROX. SEK 82.5 MILLION

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION REQUIRES A PROSPECTUS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE CONTRAVENES APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT BE MADE WITHOUT THE APPLICATION OF AN EXEMPTION FROM SUCH

Read more »